Oncology & Cancer

Toward a safer treatment for leukemia

An international team of researchers at VIB-KU Leuven, Belgium, the U.K. Dementia Institute and the Children's Cancer Institute, Australia, have found a safer treatment for a specific type of leukemia. By refining a therapeutic ...

Alzheimer's disease & dementia

New player in Alzheimer's disease pathogenesis identified

Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study, published in Nature Communications, ...

Alzheimer's disease & dementia

New drugs to find the right target to fight Alzheimer's disease

The future is looking good for drugs designed to combat Alzheimer's disease. EPFL scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease. Their research suggests ...

Medical research

Noncoding RNA may promote Alzheimer's disease

Researchers pinpoint a small RNA that spurs cells to manufacture a particular splice variant of a key neuronal protein, potentially promoting Alzheimer's disease (AD) or other types of neurodegeneration. The study appears ...

Diseases, Conditions, Syndromes

Alzheimer's disease drug treats traumatic brain injury

The destructive cellular pathways activated in Alzheimer's disease are also triggered following traumatic brain injury, say researchers from Georgetown University Medical Center (GUMC). They say this finding suggests that ...